Pulse Biosciences, Inc.PLSENASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P28
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -4.09% |
| Q3 2025 | -5.75% |
| Q2 2025 | 17.21% |
| Q1 2025 | -3.27% |
| Q4 2024 | 38.41% |
| Q3 2024 | 6.54% |
| Q2 2024 | 7.25% |
| Q1 2024 | -13.57% |
| Q4 2023 | 4.38% |
| Q3 2023 | 11.57% |
| Q2 2023 | 14.89% |
| Q1 2023 | 42.34% |
| Q4 2022 | -9.34% |
| Q3 2022 | -17.24% |
| Q2 2022 | -19.37% |
| Q1 2022 | 19.64% |
| Q4 2021 | -12.41% |
| Q3 2021 | -13.39% |
| Q2 2021 | -17.70% |
| Q1 2021 | 22.06% |
| Q4 2020 | 6.56% |
| Q3 2020 | 18.71% |
| Q2 2020 | -5.03% |
| Q1 2020 | -6.21% |
| Q4 2019 | 6.43% |
| Q3 2019 | -2.29% |
| Q2 2019 | 8.47% |
| Q1 2019 | 15.00% |
| Q4 2018 | 0.83% |
| Q3 2018 | 27.22% |
| Q2 2018 | 24.72% |
| Q1 2018 | 10.86% |
| Q4 2017 | -10.50% |
| Q3 2017 | 40.23% |
| Q2 2017 | 23.28% |
| Q1 2017 | 2.49% |
| Q4 2016 | 3.85% |
| Q3 2016 | 19.68% |
| Q2 2016 | 46.77% |
| Q1 2016 | 4.06% |